Digital biomarkers for Alzheimer's disease: the mobile/wearable devices opportunity

LC Kourtis, OB Regele, JM Wright, GB Jones - NPJ digital medicine, 2019 - nature.com
Alzheimer's Disease (AD) represents a major and rapidly growing burden to the healthcare
ecosystem. A growing body of evidence indicates that cognitive, behavioral, sensory, and …

Tau and tauopathies

T Arendt, JT Stieler, M Holzer - Brain research bulletin, 2016 - Elsevier
Most neurodegenerative diseases are characterized by intracellular aggregates of insoluble
proteins. As for the majority of these disorders, aetiology and pathogenesis are only poorly …

Primary age-related tauopathy (PART): a common pathology associated with human aging

JF Crary, JQ Trojanowski, JA Schneider… - Acta …, 2014 - Springer
We recommend a new term,“primary age-related tauopathy”(PART), to describe a pathology
that is commonly observed in the brains of aged individuals. Many autopsy studies have …

Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer's disease neurons

R Rajmohan, PH Reddy - Journal of Alzheimer's Disease, 2017 - content.iospress.com
Amyloid-beta (Aß) and hyperphosphorylated tau are hallmark lesions of Alzheimer's disease
(AD). However, the loss of synapses and dysfunctions of neurotransmission are more …

The preclinical phase of the pathological process underlying sporadic Alzheimer's disease

H Braak, K Del Tredici - Brain, 2015 - academic.oup.com
Abnormal tau lesions (non-argyrophilic pretangle material, argyrophilic neuropil threads,
neurofibrillary tangles) in select types of neurons are crucial for the pathogenesis of sporadic …

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

PT Nelson, I Alafuzoff, EH Bigio… - … of Neuropathology & …, 2012 - academic.oup.com
Clinicopathologic correlation studies are critically important for the field of Alzheimer disease
(AD) research. Studies on human subjects with autopsy confirmation entail numerous …

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years

H Braak, DR Thal, E Ghebremedhin… - … of Neuropathology & …, 2011 - academic.oup.com
Two thousand three hundred and thirty two nonselected brains from 1-to 100-year-old
individuals were examined using immunocytochemistry (AT8) and Gallyas silver staining for …

Locus coeruleus volume and cell population changes during Alzheimer's disease progression: a stereological study in human postmortem brains with potential …

P Theofilas, AJ Ehrenberg, S Dunlop, ATDL Alho… - Alzheimer's & …, 2017 - Elsevier
Introduction Alzheimer's disease (AD) progression follows a specific spreading pattern,
emphasizing the need to characterize those brain areas that degenerate first. The …

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

SJB Vos, C Xiong, PJ Visser, MS Jasielec… - The Lancet …, 2013 - thelancet.com
Background New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers …

Tau protein hyperphosphorylation and aggregation in Alzheimer's disease and other tauopathies, and possible neuroprotective strategies

G Šimić, M Babić Leko, S Wray, C Harrington, I Delalle… - Biomolecules, 2016 - mdpi.com
Abnormal deposition of misprocessed and aggregated proteins is a common final pathway
of most neurodegenerative diseases, including Alzheimer's disease (AD). AD is …